权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Candidalysin: a key mediator of Candida vaginitis immunopathology

念珠菌溶素：念珠菌阴道炎免疫病理学的关键介质

基本信息

批准号：
9767658
负责人：
Brian M Peters
金额：
$ 38万
依托单位：
UNIVERSITY OF TENNESSEE HEALTH SCI CTR
依托单位国家：
美国
项目类别：
财政年份：
2018
资助国家：
美国
起止时间：
2018-09-01 至 2022-08-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/9767658
关键词：
Affect Age Alleles Amino Acids Candida Candida albicans Candidiasis Cells Chronic Cleaved cell Clinical Clinical Management Complex Data Disease Engineering Epithelial Cells Etiology Exhibits Female of child bearing age Foundations Genetic Health Human Hyphae Immune response Immunity Immunologic Deficiency Syndromes In Vitro Infection Inflammasome Inflammation Inflammatory Integration Host Factors Interleukin-1 beta Interleukin-18 Knockout Mice Link Mediating Mediator of activation protein Medical Care Costs Molecular Mus Mutagenesis Mycoses Mycotoxins Onset of illness Oral mucous membrane structure Outcome Pain Pathogenesis Pathogenicity Pathway interactions Pattern Peptide Hydrolases Peptides Population Protein Isoforms Proteins Quality of life Recurrence Research Role Signal Pathway Signal Transduction Symptoms Testing Therapeutic Toxin Vagina Vaginitis Variant Virulence Factors Vulvovaginal Candidiasis Woman Yeasts cell injury delta opioid receptor experience fungus genetic variant immunopathology improved in vivo molecular targeted therapies mouse model neutrophil novel polypeptide prevent promoter reproductive symptomatology transcriptome sequencing vaginal fluid vaginal mucosa whole genome

项目摘要

Candida albicans, the primary causative agent of fungal vaginitis, will affect 75% of all women of reproductive age at least once in their lifetime. Long believed to result from immunodeficiency, a growing body of evidence strongly suggests that vaginitis is now considered to be an immunopathology, in which the host response actually drives disease symptoms. Lack of a comprehensive understanding of the host and fungal factors that initiate symptomatic disease high remains a barrier to progress in better treating and managing this most prevalent human fungal infection. Guided by strong preliminary data, we have identified the newly described fungal toxin Candidalysin as the major virulence factor governing vaginitis pathogenesis. Therefore, the objective of this proposal is to determine if variation in expression or activity of Candidalysin in clinical isolates governs C. albicans pathogenicity at the vaginal mucosa. These aims will test our central hypothesis that variation in Candidalysin activity partly underlies the variable symptomatology of Candida vaginal colonization and identification of host signaling engaged by Candidalysin may elucidate new molecular therapeutic targets. Under the first aim, we will determine amino acid residues that contribute to reduced pathogenicity of a variant Candidalysin observed in clinical isolates. We will also determine differential host responses to wild-type and variant Candidalysin at the vaginal mucosa. The second aim will focus on identifying prevalent genetic mechanisms (promoter sequences, Kex proteases) that control Candidalysin expression and function. We will confirm these by functional level by allelic transfers between strong and weak Candidalysin expressing strains. The third aim seeks to identify host factors elicited by Candidalysin that may drive immunopathology in vivo and determine if blockade of these signaling mechanisms can alleviate symptomatic disease. The outcomes of this project will provide foundational information regarding function of Candidalysin isoforms, genetic checkpoints of Candidalysin expression, and identify promising new pathways that may be exploited for the clinical management of vaginitis.

白色念珠菌是真菌性阴道炎的主要病原体，会影响75%的生殖女性